The "designer baby" industry refuses to die, despite setbacks and a wave of red flags Two startups chasing the commercial dream of editing human embryos collapsed in the past year - the US-based Striped Journal and Manhattan Genomics. One ran out of money, the other was torn apart by a dispute between its founders - but neither published a single scientific breakthrough to show for their efforts. However, that hasn't stopped fresh capital from pouring into the field, according to the FT report. 🔴 Prevention, a San Francisco faculty member undergoing meditation startup, raised nearly $30 million last year from backers including OpenAI Chief Sam Altman and Coinbase CEO Brian Armstrong 🔴 Nucleus Genomics, recruited by the founders of Peter Thiel, is funding germline gene-editing research at Columbia University 🔴 Cathy Tie, who founded manhattan closed, after other months launched, only after that, only after the previous gene study, only after that, only after the gene study Jeromic, only after previous months, only after a study conducted at Columbia University gen-D-D-D-D-D-D-omied, only after months, only after a study conducted at Columbia University 🔴 Cathy contact Cathy 🔴 Contact Cathy Cathy contact 🔴 🔴 Cathy Cathy contact 🔴, only after months, only after months, only after months, only after months, only After months, only after, only after, only after a study conducted at Columbia University. The companies base their work around preventing genetic diseases, but some proponents openly see using the same tools to shape traits such as intelligence. Critics warn that disease prevention marketing is the first step toward engineering desirable traits and creating "ideal" children for parents willing to pay huge sums for it. However, most startups in the sector lack scientific credibility, and efforts to improve features such as intelligence are "very slow," according to experts. The industry has been under intense scrutiny since Chinese scientist Jiankui announced in 2018 that he had created the world's first babies, an illegal experiment that led to his imprisonment and cited a long shadow on the field. Last year, three leading gene and cell therapy organizations proposed a 10-year moratorium on editing the human genome, warning that it would lead to "fattening" - the planned enhancement of offspring for privileged groups.

The "designer baby" industry refuses to die, despite setbacks and a wave of red flags Two startups chasing the commercial dream of editing human embryos collapsed in the past year - the US-based Striped Journal and Manhattan Genomics. One ran out of money, the other was torn apart by a dispute between its founders - but neither published a single scientific breakthrough to show for their efforts. However, that hasn't stopped fresh capital from pouring into the field, according to the FT report. 🔴 Prevention, a San Francisco faculty member undergoing meditation startup, raised nearly $30 million last year from backers including OpenAI Chief Sam Altman and Coinbase CEO Brian Armstrong 🔴 Nucleus Genomics, recruited by the founders of Peter Thiel, is funding germline gene-editing research at Columbia University 🔴 Cathy Tie, who founded manhattan closed, after other months launched, only after that, only after the previous gene study, only after that, only after the gene study Jeromic, only after previous months, only after a study conducted at Columbia University gen-D-D-D-D-D-D-omied, only after months, only after a study conducted at Columbia University 🔴 Cathy contact Cathy 🔴 Contact Cathy Cathy contact 🔴 🔴 Cathy Cathy contact 🔴, only after months, only after months, only after months, only after months, only After months, only after, only after, only after a study conducted at Columbia University. The companies base their work around preventing genetic diseases, but some proponents openly see using the same tools to shape traits such as intelligence. Critics warn that disease prevention marketing is the first step toward engineering desirable traits and creating "ideal" children for parents willing to pay huge sums for it. However, most startups in the sector lack scientific credibility, and efforts to improve features such as intelligence are "very slow," according to experts. The industry has been under intense scrutiny since Chinese scientist Jiankui announced in 2018 that he had created the world's first babies, an illegal experiment that led to his imprisonment and cited a long shadow on the field. Last year, three leading gene and cell therapy organizations proposed a 10-year moratorium on editing the human genome, warning that it would lead to "fattening" - the planned enhancement of offspring for privileged groups.